SLC5A2 and lobular neoplasia: With the originality of SGLT-2 inhibitors used as a treatment method for LN, it was expected the articles gathered would be limited; however, it is crucial to present this preliminary review to make clinicians aware of the further nephroprotective features of this class of medication.